Check Cap Ltd (CHEK)

• $1.79

  $1.84

  $1.79
  

  0.0%

  Downside

  Day's Volatility :2.45%

  Upside

  2.45%

  
• $1.77

  $4.63

  $1.79
  

  1.12%

  Downside

  52 Weeks Volatility :61.73%

  Upside

  61.3%

  

Returns

What analysts predicted

Upside of 291.06%

• Morgan Stanley - Brokerage Accounts

  0.06%

• Advisor Group Holdings, Inc.

  0.04%

• IFP Advisors, LLC

  0.01%

• Bank of America Corp

  0.01%

check-cap is a clinical stage medical diagnostics company leading the development of the first ingestible imaging capsule that utilizes low-dose x-rays for crc screening. the check-cap device requires no bowel preparation or invasive procedures, and is designed to detect clinically significant polyps with a high degree of sensitivity. check-cap's advanced technology has been proven in animals, and is designed to offer several advantages compared to current screening procedures. founded in early 2005, check-cap recruited a team of world-class experts in physics, software engineering, electronics, mechanics and physiology, who have been developing a multi-disciplinary imaging solution for imaging and screening of the colon. the system includes a capsule, a receiver, proprietary imaging software and an associated database for web based access and analysis. check-cap's advanced technology has been proven in animals and promises to offer several significant advantages compared to other colo